You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis B seroconversion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease Trial in Baltimore (Heplisav-B Injectable Product, 2-dose regimen,

Recruiting
  • Hepatitis B
  • +2 more
  • Heplisav-B Injectable Product, 2-dose regimen
  • Heplisav-B Injectable Product, 3-dose regimen
  • Baltimore, Maryland
    Mercy Medical Center
Aug 24, 2022

Seroconversion of Hepatitis c Virus Among CKD on Regular

Not yet recruiting
  • Hepatitis C Virus
    • (no location specified)
    Oct 25, 2023

    Chronic Hepatitis B Trial (Imdusiran (AB-729))

    Not yet recruiting
    • Chronic Hepatitis B
    • Imdusiran (AB-729)
    • (no location specified)
    Nov 30, 2023

    Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

    Recruiting
    • AIDS
    • Hepatitis B
    • Peginterferon alfa-2b Injection
    • Guangzhou, Guangdong, China
      Guangzhou Eighth People's Hospital, Guangzhou Medical University
    Aug 10, 2023

    HBsAg Declined Patients Follow-up Study

    Not yet recruiting
    • Hepatitis B
    • Hepatitis B, Chronic
      • (no location specified)
      Jul 28, 2023

      Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)

      Not yet recruiting
      • Chronic Hepatitis B
      • HRS9950 tablets
      • HRS9950 placebo tablets
      • (no location specified)
      Jun 7, 2023

      Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

      Active, not recruiting
      • Hepatitis B, Chronic
      • Tenofovir disoproxil fumarate
      • Toronto, Ontario, Canada
        University Health Network - Toronto General Hospital
      Nov 1, 2022

      Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

      Recruiting
      • Chronic HBV Infection
      • Peginterferon alfa-2b combined and ETV
      • Shenzhen, China
        Shenzhen Third People Hospital
      Mar 19, 2023

      Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

      Not yet recruiting
      • Chronic Hepatitis B
      • (no location specified)
      Feb 28, 2023

      Chronic Hepatitis B, High-Risk Cancer Trial in China (Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide

      Active, not recruiting
      • Chronic Hepatitis B
      • High-Risk Cancer
      • Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue
      • Nucleos(t)ide analogue
      • Chengdu, China
      • +8 more
      Jan 4, 2023

      Metabolic Syndrome on Antiviral Response in People With Chronic

      Not yet recruiting
      • Chronic Hepatitis b
        • (no location specified)
        Jan 21, 2023

        Chronic Hepatitis b Trial in Adelaide (Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine)

        Not yet recruiting
        • Chronic Hepatitis b
        • Therapeutic hepatitis B vaccine
        • Commercial Hepatitis B vaccine
        • Adelaide, South Australia, Australia
          Flinders University
        Mar 7, 2022

        HBV Infection, Chronic Hepatitis b Trial in China (Tenofovir Amibufenamide(TMF))

        Recruiting
        • HBV Infection
        • Chronic Hepatitis b
        • Tenofovir Amibufenamide（TMF）
        • Beijing, China
        • +11 more
        Mar 22, 2023

        Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene

        Recruiting
        • Hepatitis B, Chronic
        • genotyping
        • Sohag, Egypt
          Sohag university Hospital
        Sep 4, 2023

        Hepatitis B Vaccine Trial (60 µg dose hepatitis B vaccine, 20 µg dose hepatitis B vaccine)

        Completed
        Has Results
        • Hepatitis B Vaccine
        • 60 µg dose hepatitis B vaccine
        • 20 µg dose hepatitis B vaccine
        • (no location specified)
        Nov 26, 2021

        Tenofovir Disoproxil Fumarate and Entcavir in Treatment of

        Recruiting
        • Chronic Hepatitis b Patients
        • Tenofovir Disoproxil Fumarate and Entcavir
        • Sohag, Egypt
          Sohag University hospitals
        May 22, 2023

        Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

        Active, not recruiting
        • Hepatitis B, Chronic
        • Edegem, Belgium
        • +12 more
        Jan 17, 2023

        TDF and Entekavir - Hepatitis B Reactivation

        Recruiting
        • Hepatitis B Reactivation
          • Istanbul, Turkey
            Cerrahpasa Medical Faculty
          Sep 15, 2023

          Hepatitis B Trial in Saint Petersburg (Sci-B-Vac®, Engerix-B®)

          Completed
          Has Results
          • Hepatitis B
          • Sci-B-Vac®
          • Engerix-B®
          • Saint Petersburg, Mirgorodskaya, Russian Federation
            Saint Petersburg State Budgetary Healthcare Institution
          Mar 24, 2022

          Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

          Recruiting
          • Hepatitis B, Chronic
          • Auckland, New Zealand
          • +1 more
          Dec 19, 2022

          Hypothermia's Effect on Hepatitis B Vaccination

          Not yet recruiting
          • Hypoxic-Ischemic Encephalopathy
          • +2 more
          • Hypothermia Protocol
          • (no location specified)
          Mar 15, 2023

          Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

          Completed
          • Chronic Hepatitis B
          • PegIFN α- 2b
          • Zhengzhou, Henan, China
            Henan Provincial People's Hospital
          Jul 11, 2022

          Hepatitis B, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

          Not yet recruiting
          • Hepatitis B
          • +2 more
          • Patient Participation Form
          • (no location specified)
          Mar 3, 2023

          Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

          Not yet recruiting
          • Hepatitis B, Chronic
          • Exposure factors
          • (no location specified)
          Sep 10, 2023

          Chronic Hepatitis B Virus Infection Trial in Guangzhou (Entecavir, Entecavir combined with Tenofovir Amibufenamide)

          Recruiting
          • Chronic Hepatitis B Virus Infection
          • Entecavir
          • Entecavir combined with Tenofovir Amibufenamide
          • Guangzhou, Guangdong, China
            The Third Affiliated Hospital of Sun Yat-sen University
          May 15, 2022